Bioregenx (BRGX) Payables (2021 - 2026)

Bioregenx's Payables history runs 6 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Payables rose 73.33% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 73.33% YoY), while the FY2025 annual figure was $1.6 million, up 23.53% from the prior year.
• Payables was $1.7 million for Q1 2026 at Bioregenx, up from $1.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.7 million in Q1 2026 to a low of $34923.0 in Q1 2023.
• Historically, Payables has averaged $945716.9 across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Payables jumped 3394.4% in 2024, then dropped 21.92% in 2025.
• A 5-year view of Payables shows it stood at $60691.0 in 2022, then soared by 917.24% to $617376.0 in 2023, then soared by 112.31% to $1.3 million in 2024, then climbed by 23.53% to $1.6 million in 2025, then advanced by 2.0% to $1.7 million in 2026.
• The last three Payables figures came in at $1.7 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.